A new therapy (MP29-02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion

Samankaltaisia teoksia

• A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
  Tekijä: Fokkens, Wytske, et al.
  Julkaistu: (2015)
• Short and long-term safety of MP29-02*: a new therapy for the treatment of allergic rhinitis
  Tekijä: Price, David, et al.
  Julkaistu: (2013)
• A new therapy (MP29-02*) effectively targets the entire seasonal allergic rhinitis symptom complex
  Tekijä: Price, David, et al.
  Julkaistu: (2013)
• A new therapy (MP29-02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity
  Tekijä: Scadding, Glenis, et al.
  Julkaistu: (2013)
• MP29-02*’s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis
  Tekijä: Scadding, Glenis, et al.
  Julkaistu: (2015)